AP
Alliance Pharmaceutical Corp Stock: price and insider trades · United States
Alliance Pharmaceutical Corp: what insiders have been doing
This page follows insider dealings at Alliance Pharmaceutical Corp as filed with SEC (Form 4). The past year has been quiet: not a single insider filing for Alliance Pharmaceutical Corp. The previous disclosure was published on 17 February 2006.
Our records for Alliance Pharmaceutical Corp go back to 2006, with no purchases and 5 sales on the open market in total.
These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Insider Decl.
5
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
€10,348
5 ops. · all time
Last declaration on 17 February 2006
Declarations5 total
- 60,100 shares@ US$0.0884Common stock, $0.01 par valueSEC:0001318148-06-000203:0
- 16,000 shares@ US$0.088Common stock, $0.01 par valueSEC:0001318148-06-000203:1
- 20,000 shares@ US$0.09Common stock, $0.01 par valueSEC:0001318148-06-000203:2
- 5,000 shares@ US$0.09Common stock, $0.01 par valueSEC:0001318148-06-000203:3
- 38,900 shares@ US$0.089Common stock, $0.01 par valueSEC:0001318148-06-000203:4
5 of 5 declarations
About Alliance Pharmaceutical Corp
Alliance Pharmaceutical Corp is a company focused on the development and marketing of pharmaceutical products. It is listed on NASDAQ under the ticker symbol XNAS.
